Anzeige
Mehr »
Samstag, 03.01.2026 - Börsentäglich über 12.000 News
J.P. Morgan sieht 5.000-6.000 US-Dollar Gold!!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15.12.25Thermo Fisher Expands Gibco Bacto CD Portfolio with New E. coli Media
15.12.25Dren Bio Expands Strategic Collaboration with Sanofi
15.12.25Gaelic Laboratories Acquires Athlone Laboratories
15.12.25SOBI Agrees to Acquire Arthrosi Therapeutics
12.12.25Zealand Pharma, OTR Therapeutics Sign Deal to Develop Metabolic Disease Treatments
12.12.25Lilly to Invest $6B in New API Manufacturing Facility in Alabama
11.12.25Developer of 'Physical AI Scientists' Raises $52M
11.12.25Charles River Announces Latest Cohort of Its Cell & Gene Therapy Incubator Program
10.12.25Cytiva, Fidabio Partner to Expand Analytical Capabilities for Protein Research
10.12.25The Wellcome Sanger Institute Selects Sapio Informatics as Its Central LIMS
10.12.25Advarra Expands Its Network of Partner Applications
10.12.25Tjoapack Invests in New 170,000-Square-Foot Facility in Tennessee
10.12.25Expression Therapeutics Taps Former Pfizer, Novartis Exec as CEO
10.12.25Zydus & Formycon Partner for Keytruda Biosimilar in US & Canada
09.12.25Bora Pharmaceuticals, Corealis Pharma Partner to Provide End-to-End Services
09.12.25Ability Biotherapeutics Appoints Dr. Angele Maki as Chief Business Officer
09.12.25Marchesini Group, AST Partner to Expand Capacity and Global Network
09.12.25ProBioGen, Spica Therapeutics Partner to Advance ST101
09.12.25BenchSci Extends ASCEND Agreement with Merck
09.12.25Cellular Origins Completes $40M Series A Round
09.12.25Pfizer, YaoPharma Enter Exclusive Collaboration and License Agreement
08.12.25Mirum Pharmaceuticals to Acquire Bluejay Therapeutics
05.12.25Natera Acquires Foresight Diagnostics
05.12.25FDA Approves Bristol Myers Squibb's Breyanzi for Marginal Zone Lymphoma
05.12.25Jubilant Therapeutics Appoints New President & CEO